← All candidates
Six insider buys in the last year — $754.3K in all.
Gilbert Ray Cisneros, Jr.Small Business · Armed Servicestraded 18 Aug · filed 10 Sep · selfBought$1K–$15Kself18 Aug30d ago10 Sep7d agoGilbert Ray Cisneros, Jr.Small Business · Armed Servicestraded 5 Jun · filed 2 Jul · selfSold some$1K–$15Kself5 Jun104d ago2 Jul77d ago136 filings on record.
BSXBOSTON SCIENTIFIC CORP
NYSE · Healthcare · $63.64B
$43.91
+0.09% · Sep 16
Six insider buys in the last year — $754.3K in all.
Nothing in the last fortnight.
Price · 1Y · daily● 6 buys● 11 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$63.64B
Float
1445.0M
100% public
Short % float
Pro
Price / profit
17.8
Price / future profit
12.8
Price / sales
3.0
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Ludwig Edward J
Bought $202.9K on May 20 — 3,580 sh @ $56.68, held direct, 14% of their stake.
No completed positions to measure
Director
Habiger David C
Bought $125.8K on May 20 — 2,250 sh @ $55.92, held direct, 16% of their stake.
No completed positions to measure
Director
Morano Susan E
Bought $100.4K on Aug 25 — 2,040 sh @ $49.22, held direct, 15% of their stake.
First Form 4 on file
Congress
▸ Disclosures lag trades by 30–45 days.
16 disclosures12 mo
MemberTradeAmountOwnerTradedFiled
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
131 more transactions on Pro →Context
Wall St
$83.47 avg target
+90.1% vs today · 32 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$0.80 act+$0.01
Q4 '25$0.80 act+$0.02
Q3 '25$0.75 act+$0.04
Q2 '25$0.75 act+$0.02
Coverage
Boston Scientific Bets on WATCHMAN to Drive Structural Heart GrowthZacks · 05-26BofA Cuts PT on Boston Scientific Corporation (BSX) Over Worries for MedtechInsider Monkey · 05-26Boston Scientific Recalls Test Cardiac Device Quality And Investor ConfidenceSimply Wall St. · 05-26Why Is Boston Scientific (BSX) Down 13% Since Last Earnings Report?Zacks · 05-22
The file stays open
136 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice
